SCHEMBL8974747

SCHEMBL8974747

NS(=O)(=O)c1ccc(C2=CC(CO)C=C2c2ccc(F)cc2)nc1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.42
PTGS1 P23219 6/20 0.42
CA2 P00918 6/20 0.41
CA1 P00915 5/20 0.41
CA9 Q16790 4/20 0.41
CA4 P22748 3/20 0.41
CA5A P35218 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CA12 O43570 1/20 0.37
CA7 P43166 1/20 0.37
DRD1 P21728 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974301 0.93 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974748 0.89 CA2 (0.41) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974354 0.88 PTGS2 (0.42) PTGS2PTGS1
SCHEMBL8974405 0.88 CA1 (0.41) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974259 0.87 KIF11 (0.47) PTGS2PTGS1CA2CA1CA9
SCHEMBL8973747 0.86 PTGS2 (0.55) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974602 0.85 CA2 (0.44) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974356 0.84 CA2 (0.43) PTGS2PTGS1CA2CA1CA9
SCHEMBL8974518 0.83 PTGS2 (0.44) PTGS2PTGS1DRD1
SCHEMBL8974658 0.83 CA2 (0.41) PTGS2PTGS1CA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed